Abiopharma

News list

Director BOURLA ALBERT 🟢 acquired 24 shares (1 derivative) of PFIZER INC (PFE) Transaction Date: Dec 31, 2025 | Filing ID: 000163

Full text

News bot Jan. 5, 2026, 10:46 p.m.
🔍 BOURLA ALBERT (Director)

Company: PFIZER INC (PFE)

Report Date: 2025-12-31
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 24
Detailed Transactions and Holdings:
- Acquired 24 shares of Phantom Stock Units SSP (Derivative)
  Date: 2025-12-31 | Code: A | equity_swap_involved: 0 | shares_owned_after: 743,147.00 | transaction_form_type: 4 | Footnotes: F1, F2, F2
Footnotes:
- F1: Each unit represents one phantom share of common stock.
- F2: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.